MacroGenics | MGNX - Interest Income


MacroGenics reported $1.55M in Interest Income for its fiscal quarter ending in March of 2026.





Interest Income Change Date
AbbVie USD 72M 13M Mar/2026
AstraZeneca USD 80M 7M Jun/2026
Biogen USD 37.9M 700K Mar/2026
Daiichi Sankyo JPY 9.96B 230M Mar/2024
Eli Lilly USD 65M 25M Sep/2025
Genmab DKK 25M 8M Jun/2025
Geron USD 3.42M 624K Mar/2026
Gilead Sciences USD 95M 0 Mar/2026
J&J USD 2.27 0.13 Jun/2026
Karyopharm Therapeutics USD -0.15 0.11 Dec/2024
MacroGenics USD 1.55M 26K Mar/2026
Merck USD 35M 34M Mar/2026
Pfizer USD -0.04 115M Jun/2026
Puma Biotechnology USD 0.41 0.5 Sep/2024
Regeneron Pharmaceuticals USD 183.3M 200K Jun/2026
Xencor USD 5.46M 741K Mar/2026